H H Lundbeck A-S
H
Deschisă
41.28 3.51
Rezumat
Modificarea prețului
24h
Minim
40.1
Maxim
41.4
Venit | 1.7B 1.7B |
|---|---|
Vânzări | 1.2B 7B |
P/E Medie Sector | 10.676 49.701 |
EPS | 0.94 |
Randament dividend | 2.78 |
Marjă de profit | 23.601 |
Angajați | 5,000 |
EBITDA | 598M 2.4B |
Randament dividend Medie Sector | 2.78% 2.39% |
|---|
Capitalizare de piață | -2.1B 40B |
|---|---|
Deschiderea anterioară | 37.77 |
Închiderea anterioară | 41.28 |
H Lundbeck A-S Grafic
Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.
Știri relevante
Comparație
Modificare preț
H Lundbeck A-S Așteptări
Date financiare
Cheltuieli de vânzare și administrare
Cheltuieli de exploatare
Profit pre-impozitare
Vânzări
Costul vânzărilor
Profit brut din vânzări
Cheltuieli cu dobânzile pe datorie
EBITDA
Profit operațional
$
Despre H Lundbeck A-S
H. Lundbeck A/S, a biopharmaceutical company, engages in the research, development, production, and sale of pharmaceuticals for the treatment of psychiatric and neurological disorders in Europe, United States, and internationally. The company's principal products include Abilify Maintena/Abilify Maintena for schizophrenia and bipolar I disorder in adults; Brintellix/Trintellix to treat depressive disorders; Northera for the treatment of symptomatic neurogenic orthostatic hypotension; Vyepti for migraine prevention; and Rexulti/Rxulti to treat MDD and schizophrenia. It also provides Azilect for treating Parkinson's disease; Cipralex/Lexapro for depression; Ebixa to treat dementia; Onfi for epilepsy; Sabril for the treatment of refractory complex partial seizures and infantile spasms; Xenazine for chorea; Deanxit for depression; Cipramil for depression and anxiety; and Cisordinol to treat psychosis. The company sells its products primarily to distributors of pharmaceuticals, pharmacies, and hospitals. It has a partnership collaboration with Otsuka Pharmaceuticals Co., Ltd.; and collaboration with Alloy Therapeutics, Inc. for the discovery of novel biologics therapies. The company was founded in 1915 and is headquartered in Valby, Denmark.
